Research programme: dendritic cell vaccines - PDC*line Pharma
Latest Information Update: 25 May 2016
At a glance
- Originator PDC*line Pharma
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Lung cancer
Most Recent Events
- 23 May 2016 Preclinical trials in Lung cancer in France (Parenteral)